Medico Intercontinental Limite Share Price
Medico Intercontinental Limite Share Price Today
As of 5 Jul 2026, Medico Intercontinental Limite share price is ₹29.74. The stock opened at ₹29.79, compared to its previous close of ₹28.81. During today's trading session, Medico Intercontinental Limite share price moved in the range of ₹25.08 to ₹29.79, with an average price of ₹27.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹20.61 and a high of ₹43.00.
Medico Intercontinental Limite Returns Calculator
Medico Intercontinental Limite Shareholder Returns
Medico Intercontinental Limite Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Medico Intercontinental Limite Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹96.02 | ₹71.36 | ₹76.23 | ₹74.26 |
| Other Income | ₹0.36 | ₹0.40 | ₹0.51 | ₹0.31 |
| Total Revenue | ₹96.37 | ₹71.76 | ₹76.74 | ₹74.57 |
| Total Expenses | ₹89.40 | ₹66.32 | ₹71.79 | ₹70.34 |
| Profit Before Tax | ₹6.97 | ₹5.44 | ₹4.94 | ₹4.23 |
| Tax | ₹1.92 | ₹1.49 | ₹1.34 | ₹1.13 |
| Profit After Tax | ₹5.06 | ₹3.95 | ₹3.61 | ₹3.10 |
| EPS - Basic | ₹5.06 | ₹3.95 | ₹5.61 | ₹9.54 |
| EPS - Diluted | ₹5.06 | ₹3.95 | ₹5.61 | ₹9.54 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹6.97 | ₹5.44 | ₹4.94 | ₹4.23 |
| Income before WC changes | ₹8.62 | ₹6.10 | ₹5.58 | ₹5.25 |
| Change in Assets | -₹17.76 | ₹7.80 | -₹16.54 | ₹1.23 |
| Change in Liabilities | ₹3.84 | -₹7.03 | ₹2.15 | -₹1.46 |
| Change in WC | -₹13.92 | ₹0.77 | -₹14.39 | -₹0.23 |
| Cash flow from Operations | -₹7.11 | ₹5.58 | -₹10.10 | ₹3.85 |
| Cash flow from Investing | -₹2.19 | -₹8.54 | -₹5.38 | -₹1.30 |
| Cash flow from Financing | ₹8.63 | -₹0.46 | ₹20.41 | -₹1.20 |
| Total Cash Flow | -₹0.68 | -₹3.42 | ₹4.92 | ₹1.35 |
| Cash (Start of the year) | ₹3.37 | ₹6.79 | ₹1.87 | ₹0.51 |
| Cash (End of the year) | ₹2.69 | ₹3.37 | ₹6.79 | ₹1.87 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹19.19 | ₹17.56 | ₹9.18 | ₹3.68 |
| Current Assets | ₹56.58 | ₹38.48 | ₹49.70 | ₹28.24 |
| Total Assets | ₹75.76 | ₹56.04 | ₹58.88 | ₹31.92 |
| Current Liabilities | ₹12.76 | ₹8.99 | ₹15.36 | ₹13.03 |
| Net Current Asset | ₹43.81 | ₹29.49 | ₹34.34 | ₹15.21 |
| Non-Current Liabilities | ₹14.35 | ₹2.02 | ₹2.33 | ₹6.26 |
| Equity Capital | ₹48.65 | ₹45.03 | ₹41.19 | ₹12.64 |
| Total Equity & Liabilities | ₹75.76 | ₹56.04 | ₹58.88 | ₹31.92 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹67.13 | ₹44.04 | ₹48.88 | ₹39.25 |
| Other Income | ₹0.51 | ₹0.42 | ₹0.34 | ₹0.18 |
| Total Revenue | ₹67.64 | ₹44.45 | ₹49.23 | ₹39.43 |
| Total Expenses | ₹64.06 | ₹41.83 | ₹46.85 | ₹37.60 |
| Profit Before Tax | ₹3.58 | ₹2.62 | ₹2.38 | ₹1.83 |
| Tax | ₹1.01 | ₹0.73 | ₹0.67 | ₹0.52 |
| Profit After Tax | ₹2.57 | ₹1.90 | ₹1.70 | ₹1.31 |
| EPS - Basic | ₹2.57 | ₹1.90 | ₹2.65 | ₹4.04 |
| EPS - Diluted | ₹2.57 | ₹1.90 | ₹2.65 | ₹4.04 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹3.58 | ₹2.62 | ₹2.38 | ₹1.83 |
| Income before WC changes | ₹4.52 | ₹2.74 | ₹2.59 | ₹2.39 |
| Change in Assets | -₹14.84 | ₹9.19 | -₹17.75 | ₹0.65 |
| Change in Liabilities | ₹4.54 | -₹5.59 | ₹3.87 | -₹1.32 |
| Change in WC | -₹10.30 | ₹3.60 | -₹13.88 | -₹0.67 |
| Cash flow from Operations | -₹6.78 | ₹5.73 | -₹11.95 | ₹1.10 |
| Cash flow from Investing | -₹4.78 | -₹6.65 | -₹5.02 | -₹0.80 |
| Cash flow from Financing | ₹10.57 | -₹1.63 | ₹20.63 | ₹0.87 |
| Total Cash Flow | -₹0.99 | -₹2.54 | ₹3.66 | ₹1.17 |
| Cash (Start of the year) | ₹2.41 | ₹4.95 | ₹1.29 | ₹0.12 |
| Cash (End of the year) | ₹1.42 | ₹2.41 | ₹4.95 | ₹1.29 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹21.89 | ₹17.43 | ₹10.63 | ₹5.38 |
| Current Assets | ₹36.88 | ₹22.02 | ₹33.75 | ₹12.34 |
| Total Assets | ₹58.77 | ₹39.44 | ₹44.38 | ₹17.72 |
| Current Liabilities | ₹6.95 | ₹2.48 | ₹8.09 | ₹4.21 |
| Net Current Asset | ₹29.92 | ₹19.53 | ₹25.66 | ₹8.13 |
| Non-Current Liabilities | ₹13.16 | ₹0.86 | ₹1.99 | ₹5.86 |
| Equity Capital | ₹38.66 | ₹36.10 | ₹34.30 | ₹7.65 |
| Total Equity & Liabilities | ₹58.77 | ₹39.44 | ₹44.38 | ₹17.72 |
About Medico Intercontinental Limite
Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.
Medico Intercontinental Limite Financial Highlights
- Revenue: Medico Intercontinental Limite reported revenue of ₹85.35 crore in FY26 vs ₹95.74 crore in FY25. It showed a decrease of 10.85% on a yearly basis.
- Operating Profit: Medico Intercontinental Limite reported an operating loss of ₹9.34 crore in FY26 vs ₹6.82 crore in FY25. It showed a decrease of 236.95% on a year-on-year basis.
- Net Profit: Medico Intercontinental Limite reported a net loss of ₹11.09 crore in FY26 vs ₹4.96 crore in FY25. It showed a decrease of 323.59% on a yearly basis.
Medico Intercontinental Limite Quarterly Result Highlights
- Medico Intercontinental Limite reported revenue of ₹22.60 crore in Mar 2026, compared with ₹20.19 crore in Dec 2025, representing an increase of 11.94% on a quarter-on-quarter (QoQ) basis.
- Medico Intercontinental Limite reported an operating loss of ₹1.55 crore in Mar 2026, compared with ₹1.40 crore in Dec 2025, representing a decrease of 10.71% on a quarter-on-quarter (QoQ) basis.
- Medico Intercontinental Limite reported a loss of ₹2.35 crore in Mar 2026, compared with ₹1.68 crore in Dec 2025, reflecting a decrease of 39.88% on a QoQ basis.
- The earnings per share (EPS) of Medico Intercontinental Limite stood at ₹5.06 during Mar 2026.
Similar Stocks
FAQs on Medico Intercontinental Limite Share Price
What is Medico Intercontinental Limite share price today?
Medico Intercontinental Limite share price is ₹29.74 as on 03 Jul, 2026, 15:58 IST.
How has the Medico Intercontinental Limite share price performed in the past?
In the last 1 year, Medico Intercontinental Limite delivered a return of -24.61%. The Medico Intercontinental Limite share price hit a high of ₹43.00 and low of ₹20.61.
How much is the Mutual Fund shareholding in Medico Intercontinental Limite shares?
The Mutual Fund Shareholding in Medico Intercontinental Limite was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Medico Intercontinental Limite shares ?
The 52-week high and low of Medico Intercontinental Limite share is ₹43.00 and ₹20.61 as of 03 Jul, 2026.
What is the market cap of Medico Intercontinental Limite?
The market capitalisation of Medico Intercontinental Limite is ₹28.81 Crores as on 03 Jul, 2026.
What are the stock symbols of Medico Intercontinental Limite?
The stock symbol of Medico Intercontinental Limite is 539938 on the BSE, and the ISIN is INE858Q01019.
What was yesterday's closing price for Medico Intercontinental Limite shares ?
Medico Intercontinental Limite shares closed yesterday at ₹28.81 on BSE
How to buy Medico Intercontinental Limite shares?
To buy Medico Intercontinental Limite shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Medico Intercontinental Limite shares on Holidays?
No, shares of Medico Intercontinental Limite or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Medico Intercontinental Limite shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Medico Intercontinental Limite?
The PE and PB ratio of Medico Intercontinental Limite is -2.62 and 0.61 respectively, as on 03 Jul, 2026, 15:58 IST.